Eaton Chen, MD
Otolaryngology · New Haven, CTNPI 1619991015
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,091 of the $4,446 with a category attached, or 69.5%. 12 manufacturers reported payments, led by Intersect ENT, Inc. at 46.5% of the total. Reporting peaked in 2019 at $2,667 and has fallen 74.3% since, to $686 in 2025.
Across 73 payments — averaging $60.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$2K
- GSK$973
- Johnson & Johnson$324
- Optinose US, Inc.$291
- ARS Pharmaceuticals Operations, Inc.$137
- AstraZeneca$125
- plus $529 from 6 others
What the payments were for
- Travel & lodging$1,35430%
- Food & beverage$3,09170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 7 | $2,067 |
| GSK | 48 | $973 |
| Johnson & Johnson(2 entities) | 3 | $324 |
| Optinose US, Inc. | 5 | $291 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $137 |
| AstraZeneca | 1 | $125 |
| Novo Nordisk | 1 | $125 |
| Boehringer Ingelheim | 1 | $122 |
| Medtronic | 1 | $114 |
| Merck | 1 | $102 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,446 in reported general payments places this provider in the 80th percentile of 119 otolaryngology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 144 | $1,509 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 29 | $1,313 |
| Fluticasone Propionate | 79 | $1,275 |
| Fluocinolone Acetonide Oil | 27 | $1,002 |
| Ipratropium Bromide | 16 | $409 |
| Chlorhexidine Gluconate | 19 | $127 |
| Mometasone Furoate | 18 | $118 |
| Mupirocin | 14 | $114 |
| Montelukast Sodium | 23 | $111 |
| Amoxicillin | 26 | $103 |
| Meclizine Hcl | 12 | $102 |
| Dexamethasone | 11 | $43 |
| Tizanidine Hcl | 16 | $33 |
| Hydrochlorothiazide | 14 | $18 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in New Haven
- Sara PaiNew Haven$160K
- Richard ManesNew Haven$67K
- Howard BoeyNew Haven$19K
- Wendell YarbroughNew Haven$6K
- Ken YanagisawaNew Haven$5K
- Mark DagostinoNew Haven$5K
- Clarence SasakiNew Haven$5K
- Tiffany ChenNew Haven$3K
- Catherine BrophyNew Haven$3K
- Paul FortgangNew Haven$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.